105211-78-7

Basic information

• Product Name: 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER
• Synonyms: 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER;4-Hydroxy-3-propylbenzoicacidmethylester95%;4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER 95%;Methyl 4-hydroxy-3-propylbenzoate
• CAS NO: 105211-78-7
• Molecular Formula: C₁₁H₁₄O₃
• Molecular Weight: 194.23
• EINECS: 604-604-1
• Mol File: 105211-78-7.mol

Chemical Properties

• Boiling Point: 315.2 °C at 760 mmHg
• Flash Point: 132.5 °C
• Appearance: /
• Density: 1.109 g/cm³
• Vapor Pressure: 0.00024mmHg at 25°C
• Refractive Index: 1.53
• Storage Temp.: 2-8°C
• PKA: 8.88±0.18(Predicted)
• CAS DataBase Reference: 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER(105211-78-7)
• EPA Substance Registry System: 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER(105211-78-7)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 105211-78-7(Hazardous Substances Data)

Usage

Uses

Used in Food Industry:
4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER is used as a flavoring agent for its ability to improve the taste and aroma of food products, contributing to a more appealing sensory experience for consumers.
Used in Cosmetics Industry:
In the cosmetics industry, 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER is used as a fragrance ingredient to add pleasant scents to various cosmetic products, enhancing their appeal and consumer acceptance.
Used in Pharmaceutical Production:
4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER is utilized in the production of pharmaceuticals, where it may contribute to the development of medications with improved efficacy or sensory properties.
Used in Plastics Industry:
This chemical compound is also used in the plastics industry, potentially for enhancing the properties of plastic materials or for imparting specific characteristics such as scent or taste, depending on the application.
It is crucial to handle and store 4-HYDROXY-3-PROPYLBENZOIC ACID METHYL ESTER with care due to its potential hazards if not properly managed, ensuring safety in all its applications across different industries.

InChI:InChI=1/C11H14O3/c1-3-4-8-7-9(11(13)14-2)5-6-10(8)12/h5-7,12H,3-4H2,1-2H3

Upstream product

• 35750-24-4 methyl 4-allyloxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 53596-60-4 methyl 3-allyl-4-hydroxybenzoate 

Downstream Products

• 159590-92-8 α-(4-carbomethoxy-2-n-propylphenoxy)-3,4-methylenedioxyphenylacetic acid 
• 159591-45-4 ethyl α-(4-carbomethoxy-2-n-propylphenoxy)-3,4-methylenedioxyphenylacetate 
• 1031393-43-7 3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-n-propylphenoxy)butyl)-1,5,5-trimethylimidazolidine-2,4-dione 
• 1031401-04-3 1-(4-bromobutoxy)-4-(1,1,1,3,3,3-hexafluoro-2-(methoxymethoxy)propan-2-yl)-2-n-propylbenzene 
• 1031400-93-7 1-(benzyloxy)-4-(1,1,1,3,3,3-hexafluoro-2-(methoxymethoxy)propan-2-yl)-2-n-propylbenzene 
• 1031393-40-4 3-[4-[4-[1,1,1,3,3,3-hexafluoro-2-(methoxymethyl)oxypropan-2-yl]-2-propylphenyloxy]butyl]-1,5,5-trimethylimidazolidine-2,4-dione 
• 1031393-25-5 4-(1,1,1,3,3,3-hexafluoro-2-(methoxymethoxy)propan-2-yl)-2-n-propylphenol 
• 1031400-91-5 2-(4-(benzyloxy)-3-n-propylphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol 
• 1031400-97-1 4-(1,1,1,3,3,3-hexafluoro-2-(methoxymethoxy)propan-2-yl)-2,6-di-n-propylphenol 
• 1031396-25-4 5-(benzo[d][1,3]dioxol-5-yl)-5-ethyl-3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)-2,6-di-n-propylphenoxy)butyl)imidazolidine-2,4-dione 
• 1031396-22-1 5-ethyl-3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,6-di-n-propyl-phenoxy)butyl)-5-(4-methoxyphenyl)imidazolidine-2,4-dione 
• 1031395-90-0 5-([1,1'-biphenyl]-4-yl)-3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,6-di-n-propylphenoxy)butyl)-5-methylimidazolidine-2,4-dione 
• 1031395-50-2 3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,6-di-n-propylphenoxy)-butyl)-5-(4-isopropylphenyl)-5-methylimidazolidine-2,4-dione 
• 1031396-07-2 5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)-2,6-di-n-propylphenoxy)butyl)-5-methylimidazolidine-2,4-dione 

Relevant articles and documents

DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND ACYLSULFONAMIDES

The present invention is concerned with deuterium-enriched substituted phenoxy-(3, 4-methylenedioxy)phenylacetic acid and acylsulfonamide derivatives of general structural formula I, their optically active or pure enantiomers and diastereomers, and pharmaceutical salts thereof, Formula (I) These compounds have selective antagonist activity for endothelin receptors or both endothelin and angiotensin II receptors, and are useful in the treatment of diseases mediated by endothelin and angiotensin-II and their receptors.

Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists

A novel series of 1,3-bistrifluoromethylcarbinol derivatives that act as liver X receptor (LXR) β-selective agonists was discovered. Structure-activity relationship studies led to the identification of molecule 62, which was more effective (Emax) and selective toward LXRβ than T0901317 and GW3965. Furthermore, 62 decreased LDL-C without elevating the plasma TG level and significantly suppressed the lipid-accumulation area in the aortic arch in a Bio F1B hamster fed a diet high in fat and cholesterol. We demonstrated that our LXRβ agonist would be potentially useful as a hypolipidemic and anti-atherosclerotic agent. In this manuscript, we report the design, synthesis and pharmacology of 1,3-bistrifluoromethylcarbinol derivatives.

CARBINOL DERIVATIVES HAVING CYCLIC LINKER

[Object] To provide a novel LXRβ agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A carbinol compound represented by the following general formula (I) or salt thereof, or their solvate.

SUBSTITUTED CARBINOL COMPOUND

There is provided a novel LXRβ agonist useful as a preventative and/or therapeutic agent for arteriosclerosis; arteriosclerosis such as those resulting from diabetes; hyperlipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases caus

THROMBIN INHIBITORS

A compound which inhibits human thrombin and which has the general structure STR1

Endothelin antagonists bearing 5-membered heterocyclic amides

Phenoxyphenylacetic acids and derivatives of the general structural formula I STR1 have endothelin antagonist activity and are useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebral and cardiac i